Hearing loss is one of the most common conditions encountered by the practicing otolaryngologist. While treatment, to date, has been mainly supportive (via hearing aids) or rehabilitative (via cochlear implants) a promise for novel therapeutics seems to be closer than ever. This expert series is designed to review the present knowledge and stat of the art research in Otology and Neurotology. We focus our lectures on advances in (a) genetics of hearing loss, gene delivery and gene therapy; (b) approaches for hearing preservation and restoration including pharmaceutical interventions; and (c) new understandings of inner ear trauma and its treatments. The program does not require prior knowledge in basic science research and is designed to offer providers with sufficient knowledge to understand the current state of research, appreciate translational research on the topic, and engage in conversation with their patients about the future of therapeutics.
- Provider:American Academy of Otolaryngology – Head & Neck Surgery Foundation
- Activity Link: https://academyu.entnet.org/diweb/catalog/item?id=6164470
- Start Date: 2022-10-12 05:00:00
- End Date: 2022-10-12 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Community/Population Health, Learner Competence, Learner Knowledge, Learner Performance, Patient Health
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Neurotology, Otology